The Maharashtra government has approved the establishment of a High-Energy Medical Cyclotron Project (HEMCP) in Nagpur to further enhance cancer diagnosis, treatment, and research. This significant decision was taken during a cabinet meeting held on June 16, 2026.
The project, valued at approximately ₹300 crore, will be executed through "Mahacare" (Maharashtra Cancer Care, Research and Education Foundation). The government aims to develop Nagpur into a modern hub for radiopharmaceutical research and innovation in Central India.
The High-Energy Medical Cyclotron project is a modern scientific system used to produce specialised radioisotopes for medical applications.
These radioisotopes play a crucial role in PET-CT scans, cancer detection, nuclear medicine treatments, and medical research. According to the government, the execution of this project will enable the local production of these materials and facilitate faster medical treatment for patients.
Nagpur has been considered an ideal location for this project. Several key reasons for this include the presence of AIIMS Nagpur, the operational National Cancer Institute, and major healthcare institutions like the Government Medical College, as well as its central location in Central India. So, people from various regions within a radius of approximately 500 kilometres from Nagpur will benefit from this project.
The government has approved 30 hectares of land in the Bhansoli (Kinhi) area of Hingna Taluka, Nagpur district, for this project. Modern infrastructure, laboratories, equipment, and necessary medical facilities will be developed on this huge tract of land.
An initial allocation of ₹300 crore has been approved for the project. Regarding funding, the Medical Education Department and the Industries Department will each contribute 50 per cent. Funds for land, construction, machinery, and human resource development will be allocated following the approval of the final project report.
The Cabinet has also approved the formation of a Special Purpose Vehicle (SPV) to implement this project. This SPV will operate in accordance with the Companies Act, 2013.
The SPV will be led by the Commissioner of the Medical Education Department as Chairman, the Development Commissioner of the Industries Department as Co-Chairman, and the SPV’s Chief Executive Officer as Member-Secretary. This structure will enhance coordination in project execution and management.
Currently, the radioisotopes used for cancer diagnosis often have to be sourced from cities like Mumbai or Hyderabad.
If this facility is established in Nagpur, treatment will be faster, patient costs could decrease, research opportunities will expand, advanced PET-CT services will become more accessible, and the use of new technologies will increase. Consequently, the quality of cancer treatment is likely to improve further.
I am writing about this matter because this project could prove to be a significant milestone for Maharashtra in the fields of cancer treatment and research. Currently, many radioisotopes required for PET-CT and nuclear medicine services have to be sourced from other cities.
Once this project is implemented, patients not only from Maharashtra but also from neighbouring states will gain access to advanced medical facilities. Furthermore, it will open up new possibilities in health research and medical infrastructure.
Comments ( 0)
Leave a Comment
No comments yet. Be the first to comment!